| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |